Cohesin mutations are synthetic lethal with stimulation of WNT signaling

Autor: Jin-Shu He, Antony W. Braithwaite, Ross D. Hannan, Antonio Musio, Kate M Parsons, Parry Guilford, Jisha Antony, Amee J George, Julia A. Horsfield, Anastasia Labudina, Gregory Gimenez, Sarada Ketharnathan, Chue Vin Chin, Maria Michela Pallotta
Rok vydání: 2020
Předmět:
0301 basic medicine
Cohesin complex
Carcinogenesis
Chromosomal Proteins
Non-Histone

QH301-705.5
Science
Mutant
cohesin
Cell Cycle Proteins
Synthetic lethality
Biology
medicine.disease_cause
drug screen
General Biochemistry
Genetics and Molecular Biology

Cell Line
03 medical and health sciences
0302 clinical medicine
medicine
Animals
Humans
Biology (General)
Wnt Signaling Pathway
Zebrafish
Cancer Biology
General Immunology and Microbiology
Cohesin
General Neuroscience
Wnt signaling pathway
wnt signaling
General Medicine
Cell cycle
Chromosomes and Gene Expression
biology.organism_classification
Cell biology
030104 developmental biology
synthetic lethal
030220 oncology & carcinogenesis
Medicine
biological phenomena
cell phenomena
and immunity

Synthetic Lethal Mutations
transcription
Cell Division
Research Article
Human
Zdroj: eLife, Vol 9 (2020)
eLife
ISSN: 2050-084X
Popis: Mutations in genes encoding subunits of the cohesin complex are common in several cancers, but may also expose druggable vulnerabilities. We generated isogenic MCF10A cell lines with deletion mutations of genes encoding cohesin subunits SMC3, RAD21, and STAG2 and screened for synthetic lethality with 3009 FDA-approved compounds. The screen identified several compounds that interfere with transcription, DNA damage repair and the cell cycle. Unexpectedly, one of the top ‘hits’ was a GSK3 inhibitor, an agonist of Wnt signaling. We show that sensitivity to GSK3 inhibition is likely due to stabilization of β-catenin in cohesin-mutant cells, and that Wnt-responsive gene expression is highly sensitized in STAG2-mutant CMK leukemia cells. Moreover, Wnt activity is enhanced in zebrafish mutant for cohesin subunits stag2b and rad21. Our results suggest that cohesin mutations could progress oncogenesis by enhancing Wnt signaling, and that targeting the Wnt pathway may represent a novel therapeutic strategy for cohesin-mutant cancers.
Databáze: OpenAIRE